<DOC>
	<DOCNO>NCT01364701</DOCNO>
	<brief_summary>Clinical effectiveness fine tool evaluate treatment success combine 3 element : treatment effectivity , side effect profile patient compliance . Since 3 main PDE5i 's differ molecular structure , therapeutic profile pharmacokinetics , seem logical assume combine 2 different PDE5i 's low dosage may beneficial comparison single PDE5i maximal dose therapy . The aim study compare clinical effectiveness combination therapy ( 2 lower-dose PDE5i 's ) versus single maximal dose PDE5i therapy .</brief_summary>
	<brief_title>Evaluation Safety Effectiveness 2 Lower Dose Combined PDE5i 's Versus Single Maximal Dose PDE5i Treatment</brief_title>
	<detailed_description>This prospective , randomize , 3-arm parallel trial 60 male erectile dysfunction ( ED ) never expose PDE5i therapy ( naïve patient ) enrol . In group , every patient receive three treatment regime ( Viagra®50mg &amp; Cialis®10mg , Viagra®100mg , Cialis®20mg ) , different sequence administration .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Age range 3575 year . Sexually active IIEF ED domain score 22 Subjects premature ejaculation main sexual complaint . Subjects severe cardiovascular disease Subjects Contraindications PDE5i therapy . Namely patient receive treatment nitrate base medication patient various reason take PDE5 inhibitor ( i.e severe coronary disease , liver renal failure , concomitant medication , etc . ) .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>combination therapy</keyword>
	<keyword>Sildenafil</keyword>
	<keyword>tadalafil</keyword>
	<keyword>PDE5i</keyword>
	<keyword>No Conditions</keyword>
</DOC>